Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
David Frid, MD, is a staff physician in the Section of Preventive Cardiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute. He is board-certified in internal medicine and cardiovascular disease.
Dr. Frid is a graduate of the University of Maryland School of Medicine and also holds a Master’s degree in Nutrition from the University of Maryland. He completed his residency at the University of Massachusetts Medical Center, followed by a fellowship in Preventive Cardiology and Behavioral Medicine there and a fellowship in Cardiology at Duke University Medical Center. Between 1989 and 1993 Dr. Frid held various positions at Duke Medical Center, ending as Director of Cardiac Rehabilitation and Assistant Professor of Medicine.
After leaving Duke, Dr. Frid began a long association with the Ohio State University Medical Center where he was Medical Director of the Center for Wellness and Prevention, the Executive Health Program, the National Center of Excellence in Women’s Health and the Division of Lifestyle Enhancement. While on staff at Ohio State, Dr. Frid was Director of Preventive and Rehabilitative Cardiology and Assistant Professor of Medicine, followed by Assistant Professor of Public Health in the Ohio State University School of Public Health. From Ohio State he moved to Pfizer Corp. as a regional director of cardiovascular research, the position he held immediately prior to his appointment to the Cleveland Clinic medical staff.
Dr. Frid is the author or co-author of more than 60 articles, reviews and abstracts on treating heart disease, cardiac rehabilitation and cardiac risk factors. He serves as editor or reviewer on several prominent medical journals, including Annals of Behavioral Medicine and the Journal of Cardiovascular Rehabilitation. He is a fellow of the American Association of Cardiovascular and Pulmonary Rehabilitation and is a member of the American Heart Association and the National Lipid Association.
Cardiovascular disease, cardiovascular risk prevention, coronary artery disease, heart attack, high cholesterol, hypertension - high blood pressure, cardiac rehabilitation, cardiology, C-Reactive protein testing, exercise and cardiovascular disease, preventive cardiology
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/22/2013, Dr. Frid has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.